![](/img/cover-not-exists.png)
Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects
Arm, J. P., Bottoli, I., Skerjanec, A., Floch, D., Groenewegen, A., Maahs, S., Owen, C. E., Jones, I., Lowe, P. J.Volume:
44
Language:
english
Journal:
Clinical & Experimental Allergy
DOI:
10.1111/cea.12400
Date:
November, 2014
File:
PDF, 989 KB
english, 2014